Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility

International Journal of Oncology

Volumn 45, Issue 2, 2014, Pages 541-548

  Tameda, Masahiko ^a   Sugimoto, Kazushi ^a   Shiraki, Katsuya ^a   Yamamoto, Norihiko ^a   Okamoto, Ryuji ^a   Usui, Masanobu ^a   Ito, Masaaki ^a   Takei, Yoshiyuki ^a   Nobori, Tsutomu ^a   Kojima, Takahiro ^b   Suzuki, Hideaki ^c   Uchida, Masako ^c   Uchida, Kazuhiko ^b,c  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Research Division MCBI   (Japan)

Author keywords

Collagen triple helix repeat containing 1; Comparative genomic hybridization; Copy number alteration; Hepatocellular carcinoma; Integrin

Indexed keywords

BETA3 INTEGRIN; BIOLOGICAL MARKER; CD18 ANTIGEN; COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1; MESSENGER RNA; PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; CTHRC1 PROTEIN, HUMAN; SCLEROPROTEIN; TRANSCRIPTOME; TUMOR MARKER;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CHROMOSOME 8Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BIOSYNTHESIS; CELL MOTION; GENE DOSAGE; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; COMPARATIVE GENOMIC HYBRIDIZATION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84902590344     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2445     Document Type: Article

References (36)

1. Bosch FX, Ribes J, Diaz M and Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16, 2004. (Pubitemid 39423365)
2. Llovet JM, Ricci S, Mazzaferro V, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378-390, 2008.
3. Aleksic K, Lackner C, Geigl JB, et al: Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice. Hepatology 53: 895-904, 2011.
4. Neumann O, Kesselmeier M, Geffers R, et al: Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors. Hepatology 56: 1817-1827, 2012.
5. Nishida N, Nishimura T, Ito T, Komeda T, Fukuda Y and Nakao K: Chromosomal instability and human hepatocarcinogenesis. Histol Histopathol 18: 897-909, 2003. (Pubitemid 36773234)
6. Patil MA, Gutgemann I, Zhang J, et al: Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 26: 2050-2057, 2005. (Pubitemid 41672192)
7. Katoh H, Ojima H, Kokubu A, et al: Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. Gastroenterology 133: 1475-1486, 2007. (Pubitemid 350029748)
8. Nannya Y, Sanada M, Nakazaki K, et al: A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 65: 6071-6079, 2005. (Pubitemid 40994391)
9. Collonge-Rame MA, Bresson-Hadni S, Koch S, et al: Pattern of chromosomal imbalances in non-B virus related hepatocellular carcinoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 127: 49-52, 2001. (Pubitemid 32530093)
10. Chochi Y, Kawauchi S, Nakao M, et al: A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study. J Pathol 217: 677-684, 2009.
11. Midorikawa Y, Yamamoto S, Ishikawa S, et al: Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene 25: 5581-5590, 2006. (Pubitemid 44344109)
12. Pyagay P, Heroult M, Wang Q, et al: Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res 96: 261-268, 2005. (Pubitemid 40209374)
13. Durmus T, LeClair RJ, Park KS, Terzic A, Yoon JK and Lindner V: Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1). Gene Expr Patterns 6: 935-940, 2006. (Pubitemid 44309445)
14. Kimura H, Kwan KM, Zhang Z, et al: Cthrc1 is a positive regulator of osteoblastic bone formation. PLoS One 3: e3174, 2008.
15. West RB, Nuyten DS, Subramanian S, et al: Determination of stromal signatures in breast carcinoma. PLoS Biol 3: e187, 2005.
16. Tang L, Dai DL, Su M, Martinka M, Li G and Zhou Y: Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res 12: 3716-3722, 2006. (Pubitemid 44000252)
17. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002. (Pubitemid 36019639)
18. Beachy PA, Karhadkar SS and Berman DM: Tissue repair and stem cell renewal in carcinogenesis. Nature 432: 324-331, 2004. (Pubitemid 39551660)
19. Turashvili G, Bouchal J, Baumforth K, et al: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 7: 55, 2007.
20. Oktay M, Wary KK, Dans M, Birge RB and Giancotti FG: Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. J Cell Biol 145: 1461-1469, 1999. (Pubitemid 29310003)
21. Clark EA and Brugge JS: Integrins and signal transduction pathways: the road taken. Science 268: 233-239, 1995.
22. Giancotti FG and Ruoslahti E: Integrin signaling. Science 285: 1028-1032, 1999.
23. Maubant S, Saint-Dizier D, Boutillon M, et al: Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells. Blood 108: 3035-3044, 2006.
24. Benoit YD, Larrivee JF, Groulx JF, Stankova J, Vachon PH and Beaulieu JF: Integrin alpha8beta1 confers anoikis susceptibility to human intestinal epithelial crypt cells. Biochem Biophys Res Commun 399: 434-439, 2010.
25. Takeichi T, Mocevicius P, Deduchovas O, et al: Alpha v beta2 integrin is indispensable for CD8+ T-cell recruitment in expermental pancreatic and hepatocellular cancer. Int J Cancer 130: 2067-2076, 2012.
26. Oberyszyn TM, Conti CJ, Ross MS, et al: Beta2 integrin/ICAM-1 adhesion molecule interactions in cutaneous inflammation and tumor promotion. Carcinogenesis 19: 445-455, 1998. (Pubitemid 28375447)
27. Wu Y, Zuo J, Ji G, et al: Proapoptotic function of integrin beta(3) in human hepatocellular carcinoma cells. Clin Cancer Res 15: 60-69, 2009.
28. Jeanes AI, Wang P, Moreno-Layseca P, et al: Specific beta-containing integrins exert differential control on proliferation and two-dimensional collective cell migration in mammary epithelial cells. J Biol Chem 287: 24103-24112, 2012.
29. Jung CW, Song TJ, Lee KO, et al: Characterization of hepatocellular carcinoma cell lines based on cell adhesion molecules. Int J Mol Med 29: 1158-1164, 2012.
30. Li N, Zhang JP, Guo S, et al: Down-regulation of beta3-integrin inhibits bone metastasis of small cell lung cancer. Mol Biol Rep 39: 3029-3035, 2012.
31. Papas MG, Karatzas PS, Papanikolaou IS, et al: LFA-1 expression in a series of colorectal adenocarcinomas. J Gastrointest Cancer 43: 462-466, 2012.
32. Yamamoto S, Nishimura O, Misaki K, et al: Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev Cell 15: 23-36, 2008. (Pubitemid 351895602)
33. Veeman MT, Axelrod JD and Moon RT: A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 5: 367-377, 2003. (Pubitemid 37107667)
34. Kikuchi A and Yamamoto H: Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling. Cancer Sci 99: 202-208, 2008. (Pubitemid 351228471)
35. Park EH, Kim S, Jo JY, et al: Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells. Carcinogenesis 34: 694-702, 2013.
36. Chen YL, Wang TH, Hsu HC, Yuan RH and Jeng YM: Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis. PLoS One 8: e70324, 2013.